Skip to content
The Policy VaultThe Policy Vault

MavyretMedica

Genotype 1 or 4 hepatitis C virus with renal impairment (eGFR < 30 mL/min or ESRD), pediatric (age ≥ 3 and < 18 years) – new start

Initial criteria

  • Patient has met the Hepatitis C – Mavyret PA for PSM Policy criteria

Approval duration

as specified in the Hepatitis C – Mavyret PA for PSM Policy